HYAFLEX is recommended in the treatment of pain or joint stiffness resulting from osteoarthritis, degenerative or post-traumatic knee replacement or in combination non-pharmacologic therapy, traditional or analgesic treatment.
All synovial joints, particularly weight-bearing joints that support the weight of the body, contain acid hyaluronic viscoelastic.
This substance has lubricating properties and protecting it against shocks. The reduction of stress on the cartilage allows it to regenerate and therefore reduces the progression of osteoarthritis.
The hyaluronic acid (molecular mass 650 ~ 1200 kDa) in HYAFLEX is a natural polysaccharide derived from microorganisms (Streptococcus zooepidemicus) and then purified.
HYAFLEX is injected into the joint cavity to restore the synovial fluid.
It is recommended to administer 3 injections per treatment, at the rate of one per week.
The dosage and number of injections depends on the severity of the patient's symptoms.
The effects of treatment can persist for at least 6 months after the series of 3 injections of HYAFLEX.
Medical device injection sterile
HYAFLEX must be administered by a doctor.
- Glass syringe for single use containing 2.5 ml of product in a sterile packaging.
- One ml HYAFLEX contains 10.0 mg of sodium hyaluronate dissolved in a physiological saline solution (pH between 6.8 and 7.8).
- Cartons of 1, 3, and 25 syringes.